Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) — Net Asset Quality Index
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) has a Net Asset Quality Index of 40.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥5.55 Billion minus total liabilities of CN¥3.31 Billion yields net assets of CN¥2.24 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 301408 financial resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Net Asset Quality Index Over Time (2021–2025)
This chart shows how Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the index stands at 40.4%, representing net assets of CN¥2.24 Billion against total assets of CN¥5.55 Billion CNY. See 301408 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 301408 stock market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 39.4% | CN¥2.16 Billion | CN¥5.49 Billion | CN¥3.33 Billion | ▼ -3.3 pp |
| 2024 | 42.7% | CN¥2.06 Billion | CN¥4.83 Billion | CN¥2.77 Billion | ▼ -0.2 pp |
| 2023 | 42.9% | CN¥1.98 Billion | CN¥4.61 Billion | CN¥2.64 Billion | ▲ +6.1 pp |
| 2022 | 36.8% | CN¥947.01 Million | CN¥2.58 Billion | CN¥1.63 Billion | ▼ -3.1 pp |
| 2021 | 39.8% | CN¥785.05 Million | CN¥1.97 Billion | CN¥1.19 Billion | — |